T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis - PubMed (original) (raw)

Case Reports

. 1996 Nov 1;184(5):1791-800.

doi: 10.1084/jem.184.5.1791.

J David-Ameline, M A Peyrat, A Moreau-Aubry, D Pinczon, A Lim, J Even, G Semana, J M Berthelot, R Breathnach, M Bonneville, E Houssaint

Affiliations

Case Reports

T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis

E Scotet et al. J Exp Med. 1996.

Abstract

Rheumatoid arthritis is a multistep disorder associated with autoimmune features of yet unknown etiology. Implication of viruses such as Epstein-Barr virus (EBV) in rheumatoid arthritis pathogenesis has been suspected on the basis of several indirect observations, but thus far, a direct link between EBV and rheumatoid arthritis has not been provided. Here we show that a large fraction of T cells infiltrating affected joints from a patient with chronic rheumatoid arthritis recognizes two EBV transactivators (BZLF1 and BMLF1) in a major histocompatibility complex-restricted fashion. Responses to these EBV antigens by synovial lymphocytes from several other chronic rheumatoid arthritis patients were readily detectable. Thus these results suggest a direct contribution of EBV to chronic rheumatoid arthritis pathogenesis. They also demonstrate for the first time the occurrence of T cell responses against EBV transactivating factors, which might be central in the control of virus reactivation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1990 Mar 1;171(3):831-41 - PubMed
    1. J Exp Med. 1996 Mar 1;183(3):1215-28 - PubMed
    1. N Engl J Med. 1975 Sep 11;293(11):517-20 - PubMed
    1. Arthritis Rheum. 1977 Jun;20(5):1037-42 - PubMed
    1. N Engl J Med. 1978 Apr 20;298(16):869-71 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources